AMERICAN SKIN ASSOCIATION ANNOUNCES NEW MEDICAL ADVISORY COMMITTEE CO-CHAIR JAMES G. KRUEGER, MD, PHD

2023-01-30
高管变更
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- American Skin Association (ASA) announced today that
James G. Krueger, MD, PhD, will join its Medical Advisory Committee as Co-Chair. Dr. Krueger is the David Martin Carter Professor in Clinical Investigation and Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York, NY, USA. He also serves as Senior Attending Physician and Co-Director of the Center for Clinical and Translational Science and as Chief Executive Officer of The Rockefeller University Hospital.
"We are thrilled to announce the addition of Dr. James Krueger to our Medical Advisory Committee. Dr. Krueger's expertise in the diagnosis and treatment of inflammatory skin disorders will add tremendous value to our team," said Howard P. Milstein, Chairman of ASA.
"We welcome Dr. Krueger to our Medical Advisory Committee! His leadership and research experience will prove to be an invaluable resource as we continue to work towards our vital mission and provide hope to those suffering from skin diseases," said Dr. David Norris, President of ASA.
Dr. Krueger has practiced at Rockefeller University Hospital for 25 years and is certified by the American Board of Dermatology.  His research group at The Rockefeller University was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis and this work established that elimination of pathogenic T-cells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then, his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations.
ABOUT AMERICAN SKIN ASSOCIATION
ASA is a unique collaboration of patients, families, advocates, physicians and scientists, and has evolved over 36 years into a leading force in efforts to defeat melanoma, skin cancer, and important inflammatory and genetic skin diseases. Established to serve the now more than 100 million Americans — one third of the U.S. population — afflicted with skin disorders, the organization's mission remains to advance research, champion skin health – particularly among children, and drive public awareness about skin disease. For more information, visit americanskin.org.
American Skin Association has earned Candid's 2023 Seal of Platinum Transparency.
SOURCE American Skin Association
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。